Hologic stock is trading -12.87% below its average target price of $83.14 after dropping -2.6% during today's afternoon session. Analysts are giving the large-cap Medical Electronics company an average rating of buy and target prices ranging from $75.0 to $95.0 per share.
Hologic's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 3.6%. The stock's short ratio is 3.04. The company's insiders own 0.74% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 102.2%. In conclusion, we believe there is mixed market sentiment regarding Hologic.
Institutions Invested in Hologic
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-09-30 | Vanguard Group Inc | 12% | 28,146,171 | $2,038,908,695 |
| 2023-09-30 | Blackrock Inc. | 10% | 24,224,334 | $1,754,810,814 |
| 2023-09-30 | T. Rowe Price Investment Management, Inc. | 9% | 21,931,973 | $1,588,752,177 |
| 2023-09-30 | State Street Corporation | 5% | 11,131,393 | $806,358,136 |
| 2023-09-30 | Citadel Advisors Llc | 3% | 6,252,928 | $452,962,119 |
| 2023-09-30 | Wellington Management Group, LLP | 2% | 5,774,985 | $418,339,927 |
| 2023-09-30 | Geode Capital Management, LLC | 2% | 5,467,443 | $396,061,584 |
| 2023-09-30 | Macquarie Group Limited | 2% | 4,976,412 | $360,491,297 |
| 2023-09-30 | Victory Capital Management Inc. | 2% | 4,838,090 | $350,471,251 |
| 2023-09-30 | Renaissance Technologies, LLC | 2% | 3,609,177 | $261,448,790 |
